Observational Study of Neurofilament Light Chain (NfL) as a Biomarker in Asymptomatic Carriers of the Transthyretin (TTR) Variants and Patients With Hereditary Transthyretin-mediated (hATTR) Amyloidosis With Polyneuropathy

NCT06360289 · clinicaltrials.gov ↗

RECRUITING

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Amyloidosis, Transthyretin-Related
Asymptomatic Carrier State

Interventions

OTHER: Standard of Care

Sponsor

Alnylam Pharmaceuticals